Skip to content

Released Aug 7, 2015, after the close

10-Q filed Aug 7, 2015, 38 days after period end · 0001104659-15-057722

Q2 2015 · 10-Q
Revenue$27.74M+305.6% vs Q2 2014−4.1% vs Q1 2015
Net income—
EPS Diluted-$0.34N/M vs Q2 2014N/M vs Q1 2015
Operating Income-$42,009,000N/M
Operating Cash Flowderived-$25,554,000N/M
Free Cash Flowderived-$26,407,000N/M
Margins · derived
Operating margin-151.4%+654.4 pt vs Q2 2014

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2015Q2 2014Q2 2013Q2 2012
Revenue$27.74M$6.84M$9.66M$14.60M
EPS Diluted-$0.34-$0.44-$0.57-$0.38

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR